Kevin Windebank

1.9k total citations
54 papers, 1.2k citations indexed

About

Kevin Windebank is a scholar working on Pathology and Forensic Medicine, Oncology and Physiology. According to data from OpenAlex, Kevin Windebank has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 14 papers in Oncology and 14 papers in Physiology. Recurrent topics in Kevin Windebank's work include Histiocytic Disorders and Treatments (13 papers), Lymphoma Diagnosis and Treatment (12 papers) and Parvovirus B19 Infection Studies (10 papers). Kevin Windebank is often cited by papers focused on Histiocytic Disorders and Treatments (13 papers), Lymphoma Diagnosis and Treatment (12 papers) and Parvovirus B19 Infection Studies (10 papers). Kevin Windebank collaborates with scholars based in United Kingdom, United States and Canada. Kevin Windebank's co-authors include Vasanta Nanduri, Robert T. Abraham, Paul J. Leibson, Mark S. Pearce, Louise Parker, Kenneth L. McClain, Maurizio Aricò, Stephan Ladisch, Nicole Grois and Ulrike Pötschger and has published in prestigious journals such as Blood, The Journal of Immunology and Annals of the New York Academy of Sciences.

In The Last Decade

Kevin Windebank

52 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Windebank United Kingdom 17 586 353 335 247 231 54 1.2k
Marilyn H. Duncan United States 11 602 1.0× 329 0.9× 328 1.0× 126 0.5× 186 0.8× 19 1.0k
Oussama Abla Canada 25 816 1.4× 273 0.8× 524 1.6× 125 0.5× 391 1.7× 93 1.7k
Vasanta Nanduri United Kingdom 15 1.0k 1.7× 595 1.7× 836 2.5× 417 1.7× 188 0.8× 36 1.7k
M M Reid United Kingdom 24 149 0.3× 150 0.4× 192 0.6× 204 0.8× 202 0.9× 80 1.5k
Rose‐Marie Javier France 18 109 0.2× 222 0.6× 160 0.5× 108 0.4× 376 1.6× 72 1.3k
G. Cornu Belgium 21 255 0.4× 169 0.5× 187 0.6× 178 0.7× 142 0.6× 60 1.9k
David Rosenthal United States 20 112 0.2× 189 0.5× 77 0.2× 340 1.4× 192 0.8× 59 1.4k
Rubén D. Mantilla Colombia 25 238 0.4× 171 0.5× 350 1.0× 435 1.8× 82 0.4× 46 1.9k
L. Blum France 16 170 0.3× 65 0.2× 335 1.0× 111 0.4× 408 1.8× 53 1.1k
Brigitte Ranque France 20 92 0.2× 221 0.6× 206 0.6× 134 0.5× 56 0.2× 105 1.5k

Countries citing papers authored by Kevin Windebank

Since Specialization
Citations

This map shows the geographic impact of Kevin Windebank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Windebank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Windebank more than expected).

Fields of papers citing papers by Kevin Windebank

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Windebank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Windebank. The network helps show where Kevin Windebank may publish in the future.

Co-authorship network of co-authors of Kevin Windebank

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Windebank. A scholar is included among the top collaborators of Kevin Windebank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Windebank. Kevin Windebank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Windebank, Kevin, et al.. (2013). A Scalp Nodule in a 4‐Year‐Old Boy. Pediatric Dermatology. 30(1). 135–136. 1 indexed citations
2.
Windebank, Kevin, Richard Kirk, G. Parry, et al.. (2009). Post cardiac transplantation lymphoproliferative disorder presenting as t(8;14) Burkitt leukaemia/lymphoma treated with low intensity chemotherapy and rituximab. Pediatric Blood & Cancer. 53(3). 392–396. 16 indexed citations
3.
Windebank, Kevin & Vasanta Nanduri. (2009). Langerhans cell histiocytosis. Archives of Disease in Childhood. 94(11). 904–908. 45 indexed citations
4.
Salotti, Jane A, Vasanta Nanduri, Mark S. Pearce, et al.. (2008). Incidence and clinical features of Langerhans cell histiocytosis in the UK and Ireland. Archives of Disease in Childhood. 94(5). 376–380. 124 indexed citations
5.
Minkov, Milen, Manuel Steiner, Ulrike Pötschger, et al.. (2008). Reactivations in Multisystem Langerhans Cell Histiocytosis: Data of the International LCH Registry. The Journal of Pediatrics. 153(5). 700–705.e2. 68 indexed citations
6.
Windebank, Kevin & John J. Spinetta. (2008). Do as I say or die: Compliance in adolescents with cancer. Pediatric Blood & Cancer. 50(S5). 1099–1100. 26 indexed citations
7.
Feltbower, Richard, Richard McNally, Sally E. Kinsey, et al.. (2008). Epidemiology of leukaemia and lymphoma in children and young adults from the north of England, 1990–2002. European Journal of Cancer. 45(3). 420–427. 22 indexed citations
8.
Reynolds, B. C., Kevin Windebank, Robert Leonard, & William H. Wallace. (2004). A comparison of self‐reported satisfaction between adolescents treated in a “teenage” unit with those treated in adult or paediatric units. Pediatric Blood & Cancer. 44(3). 259–263. 31 indexed citations
9.
Bajwa, Rajinder, R Skinner, Kevin Windebank, & M M Reid. (2004). Demographic study of leukaemia presenting within the first 3 months of life in the Northern Health Region of England: Table 1. Journal of Clinical Pathology. 57(2). 186–188. 19 indexed citations
10.
11.
Tweddle, Deborah A., Andrew R. Gennery, M M Reid, et al.. (1999). POSTTRANSPLANTATION B LYMPHOBLASTIC LEUKEMIA WITH BURKITT-LIKE FEATURES1. Transplantation. 67(10). 1379–1380. 2 indexed citations
12.
Tweddle, Deborah A., et al.. (1999). Drug points: Cyclosporin neurotoxicity after chemotherapy. BMJ. 318(7191). 1113–1113. 10 indexed citations
13.
Tweddle, Deborah A., et al.. (1997). Central venous catheter use in UKCCSG oncology centres. Archives of Disease in Childhood. 77(1). 58–59. 15 indexed citations
14.
Gray, J., et al.. (1994). Changing causes of septicaemia in paediatric oncology patients: Effect of imipenem use. European Journal of Pediatrics. 153(2). 84–89. 9 indexed citations
15.
Lovat, Penny E., et al.. (1993). Serial Study of T Lymphocytes in Childhood Leukemia During Remission. Pediatric Hematology and Oncology. 10(2). 129–139. 12 indexed citations
16.
Windebank, Kevin. (1990). The cytokines are coming.. Archives of Disease in Childhood. 65(11). 1283–1285. 4 indexed citations
17.
Tefferi, Ayalew, Kevin Windebank, Michael H. Veeder, & Joseph M. Kiely. (1989). Steroid‐responsive pure red cell aplasia associated with natural killer cell lymphocytosis. American Journal of Hematology. 31(3). 211–212. 6 indexed citations
18.
Windebank, Kevin, Ayalew Tefferi, W. Anthony Smithson, et al.. (1989). Acute Megakaryocytic Leukemia (M7) in Children. Mayo Clinic Proceedings. 64(11). 1339–1351. 32 indexed citations
19.
Windebank, Kevin, Robert T. Abraham, Garth Powis, et al.. (1988). Signal transduction during human natural killer cell activation: inositol phosphate generation and regulation by cyclic AMP.. The Journal of Immunology. 141(11). 3951–3957. 117 indexed citations
20.
Moncrieff, M W, Pauline M. Emerson, Kevin Windebank, & Lois E. Shepherd. (1985). Acute lymphoblastic leukaemia presenting with hypercalcaemia. Clinical & Laboratory Haematology. 7(3). 271–273. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marilyn H. Duncan Breakdown of academic impact, for papers by Oussama Abla Breakdown of academic impact, for papers by Vasanta Nanduri Breakdown of academic impact, for papers by M M Reid Breakdown of academic impact, for papers by Rose‐Marie Javier Breakdown of academic impact, for papers by G. Cornu Breakdown of academic impact, for papers by David Rosenthal Breakdown of academic impact, for papers by Rubén D. Mantilla Breakdown of academic impact, for papers by L. Blum Breakdown of academic impact, for papers by Brigitte Ranque
Rankless by CCL
2026